Skip to main content
Erschienen in: Osteoporosis International 10/2013

01.10.2013 | Original Article

Effect of intermittent PTH (1–34) on posterolateral spinal fusion with iliac crest bone graft in an ovariectomized rat model

verfasst von: Z. Qiu, L. Wei, J. Liu, K. R. Sochacki, X. Liu, C. Bishop, M. Ebraheim, H. Yang

Erschienen in: Osteoporosis International | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Summary

Intermittent treatment with high-dose parathyroid hormone (PTH) enhances the quantity and quality of the fusion callus and reduces healing time of posterolateral spinal fusion with autologous iliac bone grafts in ovariectomized osteoporotic female Sprague–Dawley rats. Intermittent PTH (1–34) could be an appropriate adjunctive therapy for osteoporotic patients undergoing posterolateral intertransverse process fusion.

Introduction

The study was designed to test the hypothesis that intermittent administration of PTH improves spinal fusion rates in a randomized controlled, ovariectomized osteoporotic rat spinal fusion model.

Methods

Thirty-six 10-week-old Sprague–Dawley rats were ovariectomized and underwent bilateral posterolateral L4–L5 spinal fusion with autologous iliac bone graft 6 weeks later. The experimental (PTH) group (18 rats) received daily subcutaneously administered injections of PTH (1–34) at 30 μg/kg/day starting on the day of operation. The control group (18 rats) received a subcutaneously administered injection of normal saline of the same volume. Nine rats from each group were sacrificed at 4 and 6 weeks. After sacrifice, the L4–L5 vertebral segments were removed and analyzed by plain radiographs, μ-CT, histomorphometry, and serum bone metabolism marker.

Results

The PTH group had a significantly higher fusion rate and X-ray fusion score than the control group at 4 and 6 weeks (p < 0.05). μ-CT and histological analysis showed that the fusion bone volume and cortical thickness for the PTH group were significantly higher than those for the control group at 4 and 6 weeks (p < 0.05). Metabolic marker analysis also showed significant difference between the two groups. The serum osteocalcin was significantly higher in the PTH group at 4 and 6 weeks, and levels of N-terminal peptide of type I collagen were significantly higher at 4 weeks (p < 0.05).

Conclusion

Intermittent treatment with high-dose PTH enhances the quantity of the fusion callus and reduces the healing time of posterolateral spinal fusion with autologous iliac bone grafts in ovariectomized osteoporotic female Sprague–Dawley rats.
Literatur
1.
Zurück zum Zitat DeWald CJ, Stanley T (2006) Instrumentation-related complications of multilevel fusions for adult spinal deformity patients over age 65: surgical considerations and treatment options in patients with poor bone quality. Spine 31(19 Suppl):S144–S151PubMedCrossRef DeWald CJ, Stanley T (2006) Instrumentation-related complications of multilevel fusions for adult spinal deformity patients over age 65: surgical considerations and treatment options in patients with poor bone quality. Spine 31(19 Suppl):S144–S151PubMedCrossRef
2.
Zurück zum Zitat Andreassen TT, Willick GE, Morley P et al (2004) Treatment with parathyroid hormone hPTH(1–34), hPTH(1–31), and monocyclic hPTH(1–31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int 74(4):351–356PubMedCrossRef Andreassen TT, Willick GE, Morley P et al (2004) Treatment with parathyroid hormone hPTH(1–34), hPTH(1–31), and monocyclic hPTH(1–31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int 74(4):351–356PubMedCrossRef
3.
Zurück zum Zitat Rao RD, Bagaria V, Gourab K et al (2008) Autograft containment in posterolateral spine fusion. Spine J 8(4):563–569PubMedCrossRef Rao RD, Bagaria V, Gourab K et al (2008) Autograft containment in posterolateral spine fusion. Spine J 8(4):563–569PubMedCrossRef
4.
Zurück zum Zitat Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L et al (2001) Effects of daily treatment with parathyroid hormone on bone micro-architecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846–1853PubMedCrossRef Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L et al (2001) Effects of daily treatment with parathyroid hormone on bone micro-architecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846–1853PubMedCrossRef
5.
Zurück zum Zitat Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R (1993) Anabolic actions of parathyroid hormone on bone. Endocrine Rev 14:690–709 Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R (1993) Anabolic actions of parathyroid hormone on bone. Endocrine Rev 14:690–709
6.
Zurück zum Zitat Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V et al (1997) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on estrogen with osteoporosis. Lancet 350:550–555PubMedCrossRef Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V et al (1997) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on estrogen with osteoporosis. Lancet 350:550–555PubMedCrossRef
7.
Zurück zum Zitat Erben RG, Weiser H, Sinowatz F, Rambeck WA, Zucker H (1992) Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif Tissue Int 50(3):228–236PubMedCrossRef Erben RG, Weiser H, Sinowatz F, Rambeck WA, Zucker H (1992) Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif Tissue Int 50(3):228–236PubMedCrossRef
8.
Zurück zum Zitat Cecchini MG, Fleisch H, Mühibauer RC (1997) Ipriflavone inhibits bone resorption in intact and ovariectomized rats. Calcif Tissue Int 61(Suppl 1):S9–S11PubMedCrossRef Cecchini MG, Fleisch H, Mühibauer RC (1997) Ipriflavone inhibits bone resorption in intact and ovariectomized rats. Calcif Tissue Int 61(Suppl 1):S9–S11PubMedCrossRef
9.
Zurück zum Zitat Mofidi A, Sedhom M, O’Shea K et al (2005) Is high level of disability an indication for spinal fusion? Analysis of long-term outcome after posterior lumbar interbody fusion using carbon fiber cages. J Spinal Disord Tech 18(6):479–484PubMedCrossRef Mofidi A, Sedhom M, O’Shea K et al (2005) Is high level of disability an indication for spinal fusion? Analysis of long-term outcome after posterior lumbar interbody fusion using carbon fiber cages. J Spinal Disord Tech 18(6):479–484PubMedCrossRef
10.
Zurück zum Zitat Abe Y, Takahata M, Ito M et al (2007) Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1–34) in a rat spinal arthrodesis model. Bone 41(5):775–785PubMedCrossRef Abe Y, Takahata M, Ito M et al (2007) Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1–34) in a rat spinal arthrodesis model. Bone 41(5):775–785PubMedCrossRef
11.
Zurück zum Zitat Grauer JN, Bomback DA, Lugo R et al (2004) Posterolateral lumbar fusions in athymic rats: characterization of a model. Spine J 4(3):281–286PubMedCrossRef Grauer JN, Bomback DA, Lugo R et al (2004) Posterolateral lumbar fusions in athymic rats: characterization of a model. Spine J 4(3):281–286PubMedCrossRef
12.
Zurück zum Zitat Fleet JC, Bruns ME, Hock JM, Wood RJ (1994) Growth hormone and parathyroid hormone stimulate intestinal calcium absorption in aged female rats. Endocrinology 134(4):1755–1760PubMedCrossRef Fleet JC, Bruns ME, Hock JM, Wood RJ (1994) Growth hormone and parathyroid hormone stimulate intestinal calcium absorption in aged female rats. Endocrinology 134(4):1755–1760PubMedCrossRef
13.
Zurück zum Zitat Nakazawa T, Nakajima A, Shiomi K et al (2005) Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1–34) on chondrogenesis in a model of experimental fracture healing. Bone 37(5):711–719PubMedCrossRef Nakazawa T, Nakajima A, Shiomi K et al (2005) Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1–34) on chondrogenesis in a model of experimental fracture healing. Bone 37(5):711–719PubMedCrossRef
14.
Zurück zum Zitat Misof BM, Roschger P, Cosman F et al (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88(3):1150–1156PubMedCrossRef Misof BM, Roschger P, Cosman F et al (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88(3):1150–1156PubMedCrossRef
15.
Zurück zum Zitat Andreassen TT, Cacciafesta V (2004) Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. J Craniofac Surg 15(3):424–427PubMedCrossRef Andreassen TT, Cacciafesta V (2004) Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. J Craniofac Surg 15(3):424–427PubMedCrossRef
16.
Zurück zum Zitat Komrakova M, Stuermer EK, Werner C et al (2010) Effect of human parathyroid hormone hPTH (1–34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 47(3):480–492PubMedCrossRef Komrakova M, Stuermer EK, Werner C et al (2010) Effect of human parathyroid hormone hPTH (1–34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 47(3):480–492PubMedCrossRef
17.
Zurück zum Zitat Hodsman AB, Bauer DC, Dempster DW et al (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26(5):688–703PubMedCrossRef Hodsman AB, Bauer DC, Dempster DW et al (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26(5):688–703PubMedCrossRef
18.
Zurück zum Zitat Nakajima A, Shimoji N, Shiomi K et al (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 17(11):2038–2047PubMedCrossRef Nakajima A, Shimoji N, Shiomi K et al (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 17(11):2038–2047PubMedCrossRef
19.
Zurück zum Zitat Giannoudis P, Tzioupis C, Almalki T et al (2007) Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 38(Suppl 1):S90–S99PubMedCrossRef Giannoudis P, Tzioupis C, Almalki T et al (2007) Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 38(Suppl 1):S90–S99PubMedCrossRef
20.
Zurück zum Zitat Wink CS (1982) Scanning electron microscopy of castrate rat bone. Calcif Tissue Int 34(6):547–552PubMedCrossRef Wink CS (1982) Scanning electron microscopy of castrate rat bone. Calcif Tissue Int 34(6):547–552PubMedCrossRef
21.
Zurück zum Zitat Snider RK, Krumwiede NK, Snider LJ et al (1999) Factors affecting lumbar spinal fusion. J Spinal Disord 12(2):107–114PubMedCrossRef Snider RK, Krumwiede NK, Snider LJ et al (1999) Factors affecting lumbar spinal fusion. J Spinal Disord 12(2):107–114PubMedCrossRef
22.
Zurück zum Zitat Lawrence JP, Ennis F, White AP et al (2006) Effect of daily parathyroid hormone (1–34) on lumbar fusion in a rat model. Spine J 6(4):385–390PubMedCrossRef Lawrence JP, Ennis F, White AP et al (2006) Effect of daily parathyroid hormone (1–34) on lumbar fusion in a rat model. Spine J 6(4):385–390PubMedCrossRef
23.
Zurück zum Zitat O’Loughlin PF, Cunningham ME, Bukata SV et al (2009) Parathyroid hormone (1–34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine 34(2):121–130PubMedCrossRef O’Loughlin PF, Cunningham ME, Bukata SV et al (2009) Parathyroid hormone (1–34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine 34(2):121–130PubMedCrossRef
24.
Zurück zum Zitat Komatsubara S, Mori S, Mashiba T et al (2005) Human parathyroid hormone (1–34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36(4):678–687PubMedCrossRef Komatsubara S, Mori S, Mashiba T et al (2005) Human parathyroid hormone (1–34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36(4):678–687PubMedCrossRef
25.
Zurück zum Zitat Turner RT, Evans GL, Lotinun S, Lapke PD, Iwaniec UT, Morey-Holton E (2007) Dose–response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats. J Bone Miner Res 22(1):64–71PubMedCrossRef Turner RT, Evans GL, Lotinun S, Lapke PD, Iwaniec UT, Morey-Holton E (2007) Dose–response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats. J Bone Miner Res 22(1):64–71PubMedCrossRef
26.
Zurück zum Zitat Komatsu DE, Brune KA, Liu H et al (2009) Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology 150(4):1570–1579PubMedCrossRef Komatsu DE, Brune KA, Liu H et al (2009) Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology 150(4):1570–1579PubMedCrossRef
Metadaten
Titel
Effect of intermittent PTH (1–34) on posterolateral spinal fusion with iliac crest bone graft in an ovariectomized rat model
verfasst von
Z. Qiu
L. Wei
J. Liu
K. R. Sochacki
X. Liu
C. Bishop
M. Ebraheim
H. Yang
Publikationsdatum
01.10.2013
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 10/2013
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-013-2385-7

Weitere Artikel der Ausgabe 10/2013

Osteoporosis International 10/2013 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.